This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

hypofractionated stereotactic boost radiation (prostate) after normofractionated radiotherapy (prostate + seminal vesicles).

Provided treatments

  • Radiation: First part of treatment : Conformal irradiation
  • Procedure: Fiducials placement
  • Radiation: Second part : hypofractionated stereotactic boost

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01596816. The sponsor of the trial is Centre Oscar Lambret and it is looking for 76 volunteers for the current phase.
Official trial title:
Intermediate-risk Prostate Cancer : Assessment of Hypofractionated Stereotactic Boost - Prospective Phase II Study